<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomed Res Int</journal-id><journal-id journal-id-type="iso-abbrev">Biomed Res Int</journal-id><journal-id journal-id-type="publisher-id">BMRI</journal-id><journal-title-group><journal-title>BioMed Research International</journal-title></journal-title-group><issn pub-type="ppub">2314-6133</issn><issn pub-type="epub">2314-6141</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7683109</article-id><article-id pub-id-type="doi">10.1155/2020/1034325</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Natural Cinnamaldehyde and Its Derivatives Ameliorate Neuroinflammatory Pathways in Neurodegenerative Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hajinejad</surname><given-names>Mehrdad</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ghaddaripouri</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dabzadeh</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0023-6470</contrib-id><name><surname>Forouzanfar</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2242-9794</contrib-id><name><surname>Sahab-Negah</surname><given-names>Sajad</given-names></name><email>sahabnegahs@mums.ac.ir</email><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</aff><aff id="I2">
<sup>2</sup>Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</aff><aff id="I3">
<sup>3</sup>Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran</aff><aff id="I4">
<sup>4</sup>Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</aff><author-notes><fn fn-type="other"><p>Academic Editor: Vida Demarin</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>14</day><month>11</month><year>2020</year></pub-date><volume>2020</volume><elocation-id>1034325</elocation-id><history><date date-type="received"><day>25</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>15</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>31</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Mehrdad Hajinejad et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Neurodegenerative diseases are devastating and incurable disorders characterized by neuronal dysfunction. The major focus of experimental and clinical studies are conducted on the effects of natural products and their active components on neurodegenerative diseases. This review will discuss an herbal constituent known as cinnamaldehyde (CA) with the neuroprotective potential to treat neurodegenerative disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD). Accumulating evidence supports the notion that CA displays neuroprotective effects in AD and PD animal models by modulating neuroinflammation, suppressing oxidative stress, and improving the synaptic connection. CA exerts these effects through its action on multiple signaling pathways, including TLR4/NF-<italic>&#x003ba;</italic>B, NLRP3, ERK1/2-MEK, NO, and Nrf2 pathways. To summarize, CA and its derivatives have been shown to improve pathological changes in AD and PD animal models, which may provide a new therapeutic option for neurodegenerative interventions. To this end, further experimental and clinical studies are required to prove the neuroprotective effects of CA and its derivatives.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Neuroinflammation plays a critical role in the pathogenesis of both acute and chronic neurological diseases, exemplified by stroke, Alzheimer's disease (AD), Parkinson disease (PD), and depression. During the neuroinflammatory process, immune and glial cells are extremely activated and release several proinflammatory mediators that cause neural injury. Thus, treatment or prevention of neuroinflammation-mediated neural tissue dysfunction may have a potential therapeutic option against neurological diseases [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>].</p><p>Herbal drugs, such as plant, spices, and their oils, have been used from ancient times to today to treat neurological disorders [<xref rid="B3" ref-type="bibr">3</xref>]. It has been shown that herbal drugs exert anti-inflammatory properties in a variety of peripheral systems. Now, increasing evidence indicates that anti-inflammatory herbal medicine and its constituents are being verified to be a potent neuroprotector against numerous brain disorders [<xref rid="B4" ref-type="bibr">4</xref>&#x02013;<xref rid="B6" ref-type="bibr">6</xref>].</p><p>Cinnamon powder is one of the most famous spices made from the inner bark of cinnamon trees. The most common species are <italic>C. cassia</italic> (Chinese cinnamon) and <italic>C. verum</italic> (true cinnamon). These two species contain 85.3 and 90.5 percent of the cinnamaldehyde (CA) [<xref rid="B7" ref-type="bibr">7</xref>]. CA is a major bioactive of bark extract of cinnamon that is responsible for the odor and flavor of cinnamon [<xref rid="B8" ref-type="bibr">8</xref>]. This component was isolated from cinnamon for the first time by Jean-Baptiste Dumas and Eug&#x000e8;ne-Melchior P&#x000e9;ligot in 1834 and then synthesized in the laboratory by the Italian chemist, Luigi Chiozza in 1854 [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>]. Thus, CA can be obtained from natural extracts or synthesized in a laboratory. Natural CA derivatives include <italic>trans</italic>-cinnamaldehyde (TCA), 2&#x02032;-hydroxycinnamaldehyde (HCA), 2-methoxycinnamaldehyde (MCA), and 2-hydroxycinnamic (o-Coumaric acid) (<xref ref-type="fig" rid="fig1">Figure 1</xref>) [<xref rid="B11" ref-type="bibr">11</xref>]. CA derivatives are structurally identified by the presence of cinnamoyl moiety [<xref rid="B12" ref-type="bibr">12</xref>]. In their structures, the presence of highly reactive <italic>&#x003b1;</italic>,<italic>&#x003b1;</italic>-unsaturated carbonyl pharmacophore (Michael acceptor) can react with some enzymes and/or receptors as electrophiles and subsequently generate different therapeutically relevant pharmacological functions [<xref rid="B12" ref-type="bibr">12</xref>]. Natural CA and its derivatives have been extensively investigated and comprehensively reviewed with a wide range of effects, such as anticancer, antidiabetic, antifungal, and antibacterial [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>]. Besides, natural CA and its derivates have been used for neurological purposes because they have anti-inflammatory, neuroprotective, antioxidative stress, and antiapoptotic properties (<xref rid="tab1" ref-type="table">Table 1</xref>) and (<xref ref-type="fig" rid="fig2">Figure 2</xref>) [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>]. For example, CA exhibits a protective influence against glutamate-induced cytotoxicity in PC12 cells [<xref rid="B17" ref-type="bibr">17</xref>]. CA considerably attenuated cell survival, inhibited the generation of reactive oxygen species (ROS), alleviated mitochondrial membrane potential, reduced the production of cytochrome c, and decreased the activities of caspase-3 [<xref rid="B18" ref-type="bibr">18</xref>]. CA also significantly enhanced Bcl-2 (as an antiapoptotic marker) while reducing Bax (as a proapoptotic marker) expression [<xref rid="B17" ref-type="bibr">17</xref>]. Moreover, TCA as a main natural CA derivative significantly decreased LPS-induced neuronal death through the inhibition of neuroinflammation by blocking the nuclear factor kappa B (NF-<italic>&#x003ba;</italic>B) signaling pathway in vitro condition [<xref rid="B19" ref-type="bibr">19</xref>]. In the same way, HCA is another CA derivative that can inhibit neuroinflammatory signaling pathways such as NF-<italic>&#x003ba;</italic>B, extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (p-38 MAPK) by targeting low-density lipoprotein receptor-related protein 1 (LRP1). [<xref rid="B20" ref-type="bibr">20</xref>]. Therefore, natural CA and its derivatives may be used as a therapeutic agent against neuroinflammation for improving neurological disorders. However, the mechanisms of natural CA and its derivatives on neuroinflammation should be studied more than that it has. To this end, the aim of this study was to review the current status of the neuroprotective and antineuroinflammatory properties of natural CA and its derivatives and discuss their potentials as therapeutic agents in neurodegenerative diseases.</p></sec><sec id="sec2"><title>2. Natural CA and Its Derivatives Act as a Neuroprotective Agent by Targeting Neuroinflammatory Pathways</title><p>Neuroinflammation is an intrinsic brain response that involves neurons and glial cells within the central nervous system. The neuroinflammation signaling pathways are the subject of extensive experimental and clinical studies [<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>]. The NF-<italic>&#x003ba;</italic>B pathway is a main proinflammatory cytokine mediator that is activated by toll-like receptors (TLRs) [<xref rid="B24" ref-type="bibr">24</xref>]. The TLRs are the most prominent family of pattern recognition receptors that are a part of the innate immune response [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>]. Stimulation of TLRs by insult factors leads to severe inflammatory responses by releasing proinflammatory cytokines, such as interleukin-1<italic>&#x003b2;</italic> (IL-1<italic>&#x003b2;</italic>) and interleukin-18 (IL-18) [<xref rid="B27" ref-type="bibr">27</xref>]. TLR4 is a membrane receptor of TLRs which have two adaptor proteins including myeloid differentiation primary response gene 88 (MyD88-) dependent pathway and MyD88-independent pathway (TRIF-dependent pathway) [<xref rid="B28" ref-type="bibr">28</xref>]. Activation of TLR4 recruits MyD88 and activates NF-<italic>&#x003ba;</italic>B that consequently expresses proinflammatory cytokines [<xref rid="B29" ref-type="bibr">29</xref>]. Considerable data have shown that the TLR4/NF-<italic>&#x003ba;</italic>B signaling pathway plays a key role in the pathogenesis of neuroinflammation [<xref rid="B30" ref-type="bibr">30</xref>]. Therefore, attenuating the TLR4/NF-<italic>&#x003ba;</italic>B signaling pathway can be considered as a therapeutic strategy for treating brain diseases [<xref rid="B31" ref-type="bibr">31</xref>]. With this in mind, it has been revealed that CA inhibited TLR4/NF-<italic>&#x003ba;</italic>B signaling and NLRP3 (caspase-1-containing multiprotein complex) inflammasome and subsequently controlled the release of IL-1<italic>&#x003b2;</italic> and IL-18 during the inflammatory processes [<xref rid="B32" ref-type="bibr">32</xref>]. Furthermore, CA suppresses NLRP3 inflammasome activation via inhibiting the cathepsin B and P2X7R ((P2 receptors) protein expression [<xref rid="B33" ref-type="bibr">33</xref>]. In this case, TCA improves depressive-like behaviors in a chronic mild stress model by inhibiting the NF-<italic>&#x003ba;</italic>B/NLRP3 inflammasome pathway [<xref rid="B33" ref-type="bibr">33</xref>]. Also, CA not only inhibits TLR4/NF-<italic>&#x003ba;</italic>B signaling but also attenuates the increased levels of TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, C-C Motif Chemokine Ligand 2 (CCL2), and endothelial-leukocyte adhesion molecule-1 (ELAM-1) in a cerebral ischemic model that ultimately decreased leukocyte infiltration into the ischemic brain areas (<xref ref-type="fig" rid="fig3">Figure 3</xref>) [<xref rid="B32" ref-type="bibr">32</xref>]. CA also suppressed cytokine secretion from lipopolysaccharide (LPS-) activated macrophages [<xref rid="B34" ref-type="bibr">34</xref>]. Additionally, CA inhibited apoptosis and ROS generation by inhibiting NF-<italic>&#x003ba;</italic>B activity in the DRG neurons treated by high glucose as an in vitro neuropathy model [<xref rid="B35" ref-type="bibr">35</xref>].</p><p>The molecular mechanism of CA and its derivatives are not fully understood, but these results suggest that natural CA and its derivatives may introduce as a new candidate for further development as an anti-inflammatory agent for neurodegenerative diseases [<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B36" ref-type="bibr">36</xref>&#x02013;<xref rid="B40" ref-type="bibr">40</xref>].</p></sec><sec id="sec3"><title>3. CA Attenuates the Progression of Neurodegenerative Diseases</title><sec id="sec3.1"><title>3.1. Alzheimer's Disease</title><p>AD is known as a progressive age-related neurodegenerative disorder. The symptoms of AD depend on the stage of the disease that is classified into early-stage, mild, moderate, and late-stage according to the degree of cognitive impairment. AD is associated with neurological and motor dysfunction that ultimately results in progressive memory loss [<xref rid="B41" ref-type="bibr">41</xref>&#x02013;<xref rid="B43" ref-type="bibr">43</xref>]. The exact cause of AD is not well understood, but oxidative damage and excessive ROS production have been characterized at the early stage of AD. Moreover, the main hallmark pathology of AD is the accumulation of amyloid plaques and hyperphosphorylated Tau proteins in the brain that these events cause neuronal cell death through a series of toxic pathways [<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>]. Despite huge basic and clinical research on AD, there is no effective treatment to stop the progression of clinical symptoms in AD. Additionally, other pathological features such as neuroinflammation, microglial activation, acetylcholinesterase (AChE) dysregulation, synaptic impairment, and mitochondrial dysfunction play important roles in the pathogenesis of AD. Therefore, it is necessary to develop multifunctional drugs with fewer side effects to target different aspects of AD pathology [<xref rid="B46" ref-type="bibr">46</xref>&#x02013;<xref rid="B48" ref-type="bibr">48</xref>]. In this case, it has been reported that CA prevents the accumulation and formation of plaques and neurofibrillary tangles in neurons. CA also reduces the accumulation of Tau protein through interaction with the two cysteine residues in tau and prevents neuronal loss (<xref rid="tab2" ref-type="table">Table 2</xref>) [<xref rid="B49" ref-type="bibr">49</xref>]. CA extract and its polyphenolic derivatives maintain redox homeostasis through free radical scavenging activities. It has been reported that long time consumption of cinnamon downregulated oxidative stress markers in the blood [<xref rid="B50" ref-type="bibr">50</xref>]. Besides, CA significantly improved the lifespan and healthspan in male AD flies [<xref rid="B44" ref-type="bibr">44</xref>]. Furthermore, it has been reported that the administration of CA (40&#x02009;mg/kg) improved cognitive performance by increasing phosphorylated ERK1/2 in the prefrontal cortex of rats in the methamphetamine cognitive impairment model [<xref rid="B51" ref-type="bibr">51</xref>]. In addition, it has been shown that TCA possesses an ability to inhibit neuroinflammatory responses by declining the microglial activation and levels of proinflammatory mediators in the mice brain of the AD model [<xref rid="B52" ref-type="bibr">52</xref>]. Besides, TCA improves memory impairment by suppressing microglial activation [<xref rid="B53" ref-type="bibr">53</xref>]. For this reason, TCA considerably reduced nitric oxide (NO) production in microglial cells by accelerating the destabilization of inducible nitric oxide synthase (iNOS) mRNA through the disruption of the mitogen-activated protein kinase kinase (MEK1/2)-ERK1/2 pathway in a mouse memory impairment model of LPS [<xref rid="B46" ref-type="bibr">46</xref>]. TCA can also inhibit the NF-<italic>&#x003ba;</italic>B pathway through the downregulation of iNOS, Cyclo-oxygenase-2 (COX-2), and TNF-<italic>&#x003b1;</italic> gene expressions in LPS-induced microglial cells [<xref rid="B53" ref-type="bibr">53</xref>]. Similarly, TCA can decrease the iNOS levels and phosphorylated ERK1/2 in the hippocampal tissue of the LPS in vivo model [<xref rid="B46" ref-type="bibr">46</xref>]. Recently, it has been reported that TCA has a memory-enhancing effect [<xref rid="B54" ref-type="bibr">54</xref>]. TCA improved the spatial memory and locomotor activity in mice with lipopolysaccharide (LPS-) induced memory impairment by stimulating the nuclear factor erythroid 2-related factor 2 (Nrf2) and restoring superoxide dismutase and glutathione-S-transferase as the downstream antioxidant enzymes in the hippocampus. TCA also decreased the levels of IL-1<italic>&#x003b2;</italic> and caspase-3 as well as A<italic>&#x003b2;</italic>1&#x02013;42 protein accumulation in the brain of mice [<xref rid="B55" ref-type="bibr">55</xref>]. Therefore, TCA enhanced memory function through the amelioration of Nrf2, inhibition of neuroinflammation and apoptosis, and reduction of amyloid protein aggregation.</p><p>Another significant aspect of AD pathology is decreased synaptic protein expression and synaptic impairment. TCA can increase synaptic markers in the hippocampus and frontal cortex of the mouse model of neurological disorder, indicating an improvement in synaptic connection in AD [<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B56" ref-type="bibr">56</xref>]. Besides, CA polyphenolics may improve dementia through their vasorelaxant potentials and attenuating vascular cell adhesion molecule expression within the endothelial cells [<xref rid="B43" ref-type="bibr">43</xref>]. These examples show that natural CA and its derivatives can improve AD symptoms by attenuating different pathological pathways.</p></sec><sec id="sec3.2"><title>3.2. Parkinson's Disease</title><p>PD is a debilitating progressive neurodegenerative disorder characterized by degeneration and loss of dopaminergic neurons in the substantia nigra area of the midbrain [<xref rid="B54" ref-type="bibr">54</xref>]. Mitochondrial dysfunction, neuroinflammation, oxidative stress, loss of supportive molecules, and dysregulated kinase signaling are critical factors that are known to impact the pathogenesis of PD. Moreover, preclinical and clinical evidence suggests that <italic>&#x003b1;</italic>-synuclein misfolding (Lewy body) and autophagy imbalance have been reported as the molecular mechanisms underlying PD pathogenesis [<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>]. To date, there is no effective treatment to reduce the progression of PD or even to prevent its manifestation. Therefore, searching for neuroprotective agents, which can stop the underlying pathological condition and prevent further neuronal death, is needed. Among different neuroprotective agents, herbal components have long-term efficacy and safety [<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>].</p><p>Studies have been demonstrated that cinnamon has anti-inflammatory effects as well as some neuroprotective properties [<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>]. Treatment with cinnamon prevented the development of PD-like symptoms and pathology in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP-) treated mice [<xref rid="B63" ref-type="bibr">63</xref>]. The major compound in cinnamon is CA, which is metabolized into sodium benzoate (NaB) in the liver. NaB can cross the blood&#x02013;brain barrier and increase the production of neurotrophic factors in the brain. It has been reported that NaB metabolized from cinnamon can inhibit the loss of Parkin and DJ-1 (protein deglycase), regulate neurotransmitter levels, and improve motor functions in mice with PD [<xref rid="B63" ref-type="bibr">63</xref>&#x02013;<xref rid="B65" ref-type="bibr">65</xref>]. Parkin and DJ-1 are necessary proteins for supporting the survival of dopaminergic neurons while significantly decrease in the brain of PD patients [<xref rid="B66" ref-type="bibr">66</xref>]. Consequently, sodium benzoate (NaB) metabolized from cinnamon modifies the pathology of PD through the production of neurotrophic factors and inhibition of neuroinflammation [<xref rid="B64" ref-type="bibr">64</xref>]. NaB produces brain-derived neurotrophic factor and neurotrophin-3 <italic>via</italic> the activation of protein kinase A and cAMP response element-binding pathway [<xref rid="B64" ref-type="bibr">64</xref>]. On the other hand, NaB suppresses the activation of p21<sup>ras</sup>, a small G protein, and consequently decreases the activation of NF-<italic>&#x003ba;</italic>B. Following the inhibition of NF-<italic>&#x003ba;</italic>B activation, iNOS expression and NO production are reduced, which ultimately inhibits the neuroinflammation in PD [<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B67" ref-type="bibr">67</xref>]. Furthermore, the inhibition of LPS-induced production of NO and expression of iNOS, COX-2, and IL-1<italic>&#x003b2;</italic> is the molecular mechanism behind TCA-mediated neuroprotective effects [<xref rid="B19" ref-type="bibr">19</xref>]. CA also exerted antioxidant activity by decreasing ROS production in 6-hydroxydopamine-induced cytotoxicity (<xref rid="tab1" ref-type="table">Table 1</xref>) [<xref rid="B68" ref-type="bibr">68</xref>]. Recently, it has been shown that CA could block dysregulated autophagy in MPTP as a PD model [<xref rid="B69" ref-type="bibr">69</xref>]. In general, it seems that CA has a neuroprotective effect in PD models and might be a promising therapeutic target for PD.</p></sec></sec><sec id="sec4"><title>4. Conclusion Remarks and Future Perspectives</title><p>The current treatment for neurodegenerative diseases is based on synthetic drugs that show undesirable side effects or toxicity. On the other hand, natural components are thought to be relatively safe and effective; therefore, many researchers have focused to find herbal products with neuroprotective effects. Initial experimental studies have shown that natural CA and its derivatives have therapeutic effects via modulation of several mechanisms, such as inflammation, mitochondrial dysfunction, and synaptic connection in neurodegenerative diseases, such as AD and PD. However, further studies in animal models and clinical trials are needed to clarify the safety and efficacy of CA and its derivatives as a potential therapeutic option for neurodegenerative disorders.</p></sec></body><back><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>All authors declared that there is no conflict of interest.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kempuraj</surname><given-names>D.</given-names></name><name><surname>Thangavel</surname><given-names>R.</given-names></name><name><surname>Natteru</surname><given-names>P. A.</given-names></name><etal/></person-group><article-title>Neuroinflammation induces neurodegeneration</article-title><source><italic toggle="yes">Journal of neurology, neurosurgery and spine</italic></source><year>2016</year><volume>1</volume><issue>1</issue><?supplied-pmid 28127589?><pub-id pub-id-type="pmid">28127589</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyman</surname><given-names>M.</given-names></name><name><surname>Lloyd</surname><given-names>D. G.</given-names></name><name><surname>Ji</surname><given-names>X.</given-names></name><name><surname>Vizcaychipi</surname><given-names>M. P.</given-names></name><name><surname>Ma</surname><given-names>D.</given-names></name></person-group><article-title>Neuroinflammation: the role and consequences</article-title><source><italic toggle="yes">Neuroscience Research</italic></source><year>2014</year><volume>79</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.neures.2013.10.004</pub-id><pub-id pub-id-type="other">2-s2.0-84896738387</pub-id><?supplied-pmid 24144733?><pub-id pub-id-type="pmid">24144733</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekor</surname><given-names>M.</given-names></name></person-group><article-title>The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety</article-title><source><italic toggle="yes">Frontiers in Pharmacology</italic></source><year>2014</year><volume>4</volume><fpage>p. 177</fpage><pub-id pub-id-type="doi">10.3389/fphar.2013.00177</pub-id><pub-id pub-id-type="other">2-s2.0-84893445474</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abushouk</surname><given-names>A. I.</given-names></name><name><surname>Negida</surname><given-names>A.</given-names></name><name><surname>Ahmed</surname><given-names>H.</given-names></name><name><surname>Abdel-Daim</surname><given-names>M. M.</given-names></name></person-group><article-title>Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: future applications in Parkinson&#x02019;s disease</article-title><source><italic toggle="yes">Biomedicine &#x00026; Pharmacotherapy</italic></source><year>2017</year><volume>85</volume><fpage>635</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.11.074</pub-id><pub-id pub-id-type="other">2-s2.0-85011971642</pub-id><?supplied-pmid 27890431?><pub-id pub-id-type="pmid">27890431</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manayi</surname><given-names>A.</given-names></name><name><surname>Omidpanah</surname><given-names>S.</given-names></name><name><surname>Barreca</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Neuroprotective effects of paeoniflorin in neurodegenerative diseases of the central nervous system</article-title><source><italic toggle="yes">Phytochemistry Reviews</italic></source><year>2017</year><volume>16</volume><issue>6</issue><fpage>1173</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1007/s11101-017-9527-z</pub-id><pub-id pub-id-type="other">2-s2.0-85026536310</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reglodi</surname><given-names>D.</given-names></name><name><surname>Renaud</surname><given-names>J.</given-names></name><name><surname>Tamas</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides</article-title><source><italic toggle="yes">Progress in Neurobiology</italic></source><year>2017</year><volume>155</volume><fpage>120</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.10.004</pub-id><pub-id pub-id-type="other">2-s2.0-84959449096</pub-id><?supplied-pmid 26542398?><pub-id pub-id-type="pmid">26542398</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>A. A.</given-names></name><name><surname>Stephens</surname><given-names>J. C.</given-names></name></person-group><article-title>A review of cinnamaldehyde and its derivatives as antibacterial agents</article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2019</year><volume>139</volume><fpage>p. 104405</fpage><pub-id pub-id-type="doi">10.1016/j.fitote.2019.104405</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>M.</given-names></name></person-group><article-title>Chemistry, antimicrobial mechanisms, and antibiotic activities of cinnamaldehyde against pathogenic bacteria in animal feeds and human foods</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2017</year><volume>65</volume><issue>48</issue><fpage>10406</fpage><lpage>10423</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b04344</pub-id><pub-id pub-id-type="other">2-s2.0-85037544119</pub-id><?supplied-pmid 29155570?><pub-id pub-id-type="pmid">29155570</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashakirin</surname><given-names>S. N.</given-names></name><name><surname>Tripathy</surname><given-names>M.</given-names></name><name><surname>Patil</surname><given-names>U. K.</given-names></name><name><surname>Majeed</surname><given-names>A. B. A.</given-names></name></person-group><article-title>Chemistry and bioactivity of cinnamaldehyde: a natural molecule of medicinal importance</article-title><source><italic toggle="yes">International Journal of Pharmaceutical Sciences and Research</italic></source><year>2017</year><volume>8</volume><issue>6</issue><fpage>2333</fpage><lpage>2340</lpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathirana</surname><given-names>H.</given-names></name><name><surname>Wimalasena</surname><given-names>S. H. M. P.</given-names></name><name><surname>de Silva</surname><given-names>B. C. J.</given-names></name><name><surname>Hossain</surname><given-names>S.</given-names></name><name><surname>Heo</surname><given-names>G. J.</given-names></name></person-group><article-title>Antibacterial activity of cinnamon (Cinnamomum zeylanicum) essential oil and cinnamaldehyde against fish pathogenic bacteria isolated from cultured olive flounder Paralichthys olivaceus</article-title><source><italic toggle="yes">Indian Journal of Fisheries</italic></source><year>2019</year><volume>66</volume><issue>2</issue><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.21077/ijf.2019.66.2.85023-12</pub-id><pub-id pub-id-type="other">2-s2.0-85071695902</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S. H.</given-names></name><name><surname>Ismail</surname><given-names>I. A.</given-names></name><name><surname>Kang</surname><given-names>S. M.</given-names></name><name><surname>Han</surname><given-names>D. C.</given-names></name><name><surname>Kwon</surname><given-names>B. M.</given-names></name></person-group><article-title>Cinnamaldehydes in cancer chemotherapy</article-title><source><italic toggle="yes">Phytotherapy Research</italic></source><year>2016</year><volume>30</volume><issue>5</issue><fpage>754</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1002/ptr.5592</pub-id><pub-id pub-id-type="other">2-s2.0-84959162861</pub-id><pub-id pub-id-type="pmid">26890810</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B. J.</given-names></name><name><surname>Fu</surname><given-names>C. S.</given-names></name><name><surname>Li</surname><given-names>G. H.</given-names></name><etal/></person-group><article-title>Cinnamaldehyde analogues as potential therapeutic agents</article-title><source><italic toggle="yes">Mini Reviews in Medicinal Chemistry</italic></source><year>2017</year><volume>17</volume><issue>1</issue><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.2174/1389557516666160121120744</pub-id><pub-id pub-id-type="other">2-s2.0-85016393435</pub-id><?supplied-pmid 26791737?><pub-id pub-id-type="pmid">26791737</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shreaz</surname><given-names>S.</given-names></name><name><surname>Wani</surname><given-names>W. A.</given-names></name><name><surname>Behbehani</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>Cinnamaldehyde and its derivatives, a novel class of antifungal agents</article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2016</year><volume>112</volume><fpage>116</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2016.05.016</pub-id><pub-id pub-id-type="other">2-s2.0-84974555878</pub-id><?supplied-pmid 27259370?><pub-id pub-id-type="pmid">27259370</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Cinnamaldehyde in diabetes: a review of pharmacology, pharmacokinetics and safety</article-title><source><italic toggle="yes">Pharmacological Research</italic></source><year>2017</year><volume>122</volume><fpage>78</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2017.05.019</pub-id><pub-id pub-id-type="other">2-s2.0-85020129944</pub-id><?supplied-pmid 28559210?><pub-id pub-id-type="pmid">28559210</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domadia</surname><given-names>P.</given-names></name><name><surname>Swarup</surname><given-names>S.</given-names></name><name><surname>Bhunia</surname><given-names>A.</given-names></name><name><surname>Sivaraman</surname><given-names>J.</given-names></name><name><surname>Dasgupta</surname><given-names>D.</given-names></name></person-group><article-title>Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde</article-title><source><italic toggle="yes">Biochemical Pharmacology</italic></source><year>2007</year><volume>74</volume><issue>6</issue><fpage>831</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2007.06.029</pub-id><pub-id pub-id-type="other">2-s2.0-34547655715</pub-id><?supplied-pmid 17662960?><pub-id pub-id-type="pmid">17662960</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youn</surname><given-names>H. S.</given-names></name><name><surname>Lee</surname><given-names>J. K.</given-names></name><name><surname>Choi</surname><given-names>Y. J.</given-names></name><etal/></person-group><article-title>Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization</article-title><source><italic toggle="yes">Biochemical Pharmacology</italic></source><year>2008</year><volume>75</volume><issue>2</issue><fpage>494</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2007.08.033</pub-id><pub-id pub-id-type="other">2-s2.0-37449018934</pub-id><pub-id pub-id-type="pmid">17920563</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>C.</given-names></name><name><surname>Yuan</surname><given-names>X.</given-names></name><name><surname>Zeng</surname><given-names>H. W.</given-names></name><name><surname>Liu</surname><given-names>R. H.</given-names></name><name><surname>Zhang</surname><given-names>W. D.</given-names></name></person-group><article-title>Protective effect of cinnamaldehyde against glutamate-induced oxidative stress and apoptosis in PC12 cells</article-title><source><italic toggle="yes">European Journal of Pharmacology</italic></source><year>2017</year><volume>815</volume><fpage>487</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2017.09.009</pub-id><pub-id pub-id-type="other">2-s2.0-85031713244</pub-id><?supplied-pmid 28893578?><pub-id pub-id-type="pmid">28893578</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y. H.</given-names></name></person-group><article-title>Trans-cinnamaldehyde protects C2C12 myoblasts from DNA damage, mitochondrial dysfunction and apoptosis caused by oxidative stress through inhibiting ROS production</article-title><source><italic toggle="yes">Genes &#x00026; Genomics</italic></source><year>2020</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s13258-020-00987-9</pub-id><pub-id pub-id-type="pmid">31612375</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>trans-Cinnamaldehyde inhibits microglial activation and improves neuronal survival against neuroinflammation in BV2 microglial cells with lipopolysaccharide stimulation</article-title><source><italic toggle="yes">Evidence-based Complementary and Alternative Medicine</italic></source><year>2017</year><volume>2017</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.1155/2017/4730878</pub-id><pub-id pub-id-type="other">2-s2.0-85042234907</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>H.</given-names></name><name><surname>Jeon</surname><given-names>H.</given-names></name><name><surname>Ock</surname><given-names>J.</given-names></name><etal/></person-group><article-title>2&#x02032;-Hydroxycinnamaldehyde targets low-density lipoprotein receptor-related protein-1 to inhibit lipopolysaccharide-induced microglial activation</article-title><source><italic toggle="yes">Journal of Neuroimmunology</italic></source><year>2011</year><volume>230</volume><issue>1-2</issue><fpage>52</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2010.08.021</pub-id><pub-id pub-id-type="other">2-s2.0-78650977518</pub-id><?supplied-pmid 20933287?><pub-id pub-id-type="pmid">20933287</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sochocka</surname><given-names>M.</given-names></name><name><surname>Diniz</surname><given-names>B. S.</given-names></name><name><surname>Leszek</surname><given-names>J.</given-names></name></person-group><article-title>Inflammatory response in the CNS: friend or foe?</article-title><source><italic toggle="yes">Molecular Neurobiology</italic></source><year>2017</year><volume>54</volume><issue>10</issue><fpage>8071</fpage><lpage>8089</lpage><pub-id pub-id-type="doi">10.1007/s12035-016-0297-1</pub-id><pub-id pub-id-type="other">2-s2.0-84997496789</pub-id><?supplied-pmid 27889895?><pub-id pub-id-type="pmid">27889895</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q.&#x02010;q.</given-names></name><name><surname>Zhou</surname><given-names>J.&#x02010;w.</given-names></name></person-group><article-title>Neuroinflammation in the central nervous system: symphony of glial cells</article-title><source><italic toggle="yes">Glia</italic></source><year>2019</year><volume>67</volume><issue>6</issue><fpage>1017</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1002/glia.23571</pub-id><pub-id pub-id-type="other">2-s2.0-85058229463</pub-id><?supplied-pmid 30548343?><pub-id pub-id-type="pmid">30548343</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiSabato</surname><given-names>D. J.</given-names></name><name><surname>Quan</surname><given-names>N.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name></person-group><article-title>Neuroinflammation: the devil is in the details</article-title><source><italic toggle="yes">Journal of Neurochemistry</italic></source><year>2016</year><volume>139</volume><fpage>136</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1111/jnc.13607</pub-id><pub-id pub-id-type="other">2-s2.0-84964928591</pub-id><?supplied-pmid 26990767?><pub-id pub-id-type="pmid">26990767</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>V.</given-names></name></person-group><article-title>Toll-like receptors in the pathogenesis of neuroinflammation</article-title><source><italic toggle="yes">Journal of Neuroimmunology</italic></source><year>2019</year><volume>332</volume><fpage>16</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2019.03.012</pub-id><pub-id pub-id-type="other">2-s2.0-85063536274</pub-id><pub-id pub-id-type="pmid">30928868</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voet</surname><given-names>S.</given-names></name><name><surname>Srinivasan</surname><given-names>S.</given-names></name><name><surname>Lamkanfi</surname><given-names>M.</given-names></name><name><surname>Loo</surname><given-names>G.</given-names></name></person-group><article-title>Inflammasomes in neuroinflammatory and neurodegenerative diseases</article-title><source><italic toggle="yes">EMBO Molecular Medicine</italic></source><year>2019</year><volume>11</volume><issue>6</issue><fpage>p. 11(6)</fpage><pub-id pub-id-type="doi">10.15252/emmm.201810248</pub-id><pub-id pub-id-type="other">2-s2.0-85064631879</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Saavedra</surname><given-names>V.</given-names></name><name><surname>Moghaddas</surname><given-names>F.</given-names></name><name><surname>Latz</surname><given-names>E.</given-names></name><name><surname>Masters</surname><given-names>S. L.</given-names></name></person-group><article-title>Pattern recognition receptors in autoinflammation</article-title><source><italic toggle="yes">textbook of autoinflammation</italic></source><year>2019</year><publisher-name>Springer</publisher-name><fpage>61</fpage><lpage>87.</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-98605-0_4</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Pattern recognition receptors and inflammation</article-title><source><italic toggle="yes">Cell</italic></source><year>2010</year><volume>140</volume><issue>6</issue><fpage>805</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id><pub-id pub-id-type="other">2-s2.0-77950343791</pub-id><pub-id pub-id-type="pmid">20303872</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Hua</surname><given-names>X.</given-names></name><name><surname>Kong</surname><given-names>D.</given-names></name><name><surname>Stein</surname><given-names>D.</given-names></name><name><surname>Hua</surname><given-names>F.</given-names></name></person-group><article-title>Role of Toll-like receptor mediated signaling in traumatic brain injury</article-title><source><italic toggle="yes">Neuropharmacology</italic></source><year>2019</year><volume>145</volume><issue>Part B</issue><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.07.022</pub-id><pub-id pub-id-type="other">2-s2.0-85050905914</pub-id><?supplied-pmid 30075158?><pub-id pub-id-type="pmid">30075158</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>Y.</given-names></name><name><surname>Le</surname><given-names>Y.</given-names></name></person-group><article-title>Toll-like receptors in inflammation of the central nervous system</article-title><source><italic toggle="yes">International Immunopharmacology</italic></source><year>2011</year><volume>11</volume><issue>10</issue><fpage>1407</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2011.04.025</pub-id><pub-id pub-id-type="other">2-s2.0-80053283856</pub-id><pub-id pub-id-type="pmid">21600311</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>F.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><etal/></person-group><article-title>MG53 attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation via inhibiting TLR4/NF-<italic>&#x003ba;</italic>B pathway in vitro and in vivo</article-title><source><italic toggle="yes">Progress in Neuro-Psychopharmacology and Biological Psychiatry</italic></source><year>2019</year><volume>95</volume><fpage>p. 109684</fpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2019.109684</pub-id><pub-id pub-id-type="other">2-s2.0-85068207131</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heneka</surname><given-names>M. T.</given-names></name><name><surname>Kummer</surname><given-names>M. P.</given-names></name><name><surname>Latz</surname><given-names>E.</given-names></name></person-group><article-title>Innate immune activation in neurodegenerative disease</article-title><source><italic toggle="yes">Nature Reviews Immunology</italic></source><year>2014</year><volume>14</volume><issue>7</issue><fpage>463</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1038/nri3705</pub-id><pub-id pub-id-type="other">2-s2.0-84903269246</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia</article-title><source><italic toggle="yes">British Journal of Pharmacology</italic></source><year>2015</year><volume>172</volume><issue>20</issue><fpage>5009</fpage><lpage>5023</lpage><pub-id pub-id-type="doi">10.1111/bph.13270</pub-id><pub-id pub-id-type="other">2-s2.0-84945281479</pub-id><pub-id pub-id-type="pmid">26234631</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Yan</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>P.</given-names></name></person-group><article-title>trans-Cinnamaldehyde reverses depressive-like behaviors in chronic unpredictable mild stress rats by inhibiting NF-<italic>&#x003ba;</italic>B/NLRP3 inflammasome pathway</article-title><source><italic toggle="yes">Evidence-based Complementary and Alternative Medicine</italic></source><year>2020</year><volume>2020</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1155/2020/4572185</pub-id><pub-id pub-id-type="publisher-id">4572185</pub-id><?supplied-pmid 32328132?><pub-id pub-id-type="pmid">32328132</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ka</surname><given-names>S.-M.</given-names></name><name><surname>Kuoping Chao</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>J. C.</given-names></name><etal/></person-group><article-title>A low toxicity synthetic cinnamaldehyde derivative ameliorates renal inflammation in mice by inhibiting NLRP3 inflammasome and its related signaling pathways</article-title><source><italic toggle="yes">Free Radical Biology and Medicine</italic></source><year>2016</year><volume>91</volume><fpage>10</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.12.003</pub-id><pub-id pub-id-type="other">2-s2.0-84951099749</pub-id><?supplied-pmid 26675345?><pub-id pub-id-type="pmid">26675345</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Liang</surname><given-names>X. C.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Anti-oxidative and anti-inflammatory effects of cinnamaldehyde on protecting high glucose-induced damage in cultured dorsal root ganglion neurons of rats</article-title><source><italic toggle="yes">Chinese Journal of Integrative Medicine</italic></source><year>2016</year><volume>22</volume><issue>1</issue><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1007/s11655-015-2103-8</pub-id><pub-id pub-id-type="other">2-s2.0-84953349290</pub-id><pub-id pub-id-type="pmid">26577110</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Cinnamaldehyde ameliorates LPS-induced cardiac dysfunction via TLR4-NOX4 pathway: the regulation of autophagy and ROS production</article-title><source><italic toggle="yes">Journal of Molecular and Cellular Cardiology</italic></source><year>2016</year><volume>101</volume><fpage>11</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2016.10.017</pub-id><pub-id pub-id-type="other">2-s2.0-85006827029</pub-id><?supplied-pmid 27838370?><pub-id pub-id-type="pmid">27838370</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schink</surname><given-names>A.</given-names></name><name><surname>Naumoska</surname><given-names>K.</given-names></name><name><surname>Kitanovski</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Anti-inflammatory effects of cinnamon extract and identification of active compounds influencing the TLR2 and TLR4 signaling pathways</article-title><source><italic toggle="yes">Food &#x00026; Function</italic></source><year>2018</year><volume>9</volume><issue>11</issue><fpage>5950</fpage><lpage>5964</lpage><pub-id pub-id-type="doi">10.1039/C8FO01286E</pub-id><pub-id pub-id-type="other">2-s2.0-85056504233</pub-id><pub-id pub-id-type="pmid">30379176</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Wen</surname><given-names>T.</given-names></name><name><surname>Sang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Zeng</surname><given-names>N.</given-names></name></person-group><article-title>Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice</article-title><source><italic toggle="yes">Immunopharmacology and Immunotoxicology</italic></source><year>2017</year><volume>39</volume><issue>5</issue><fpage>296</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1080/08923973.2017.1355377</pub-id><pub-id pub-id-type="other">2-s2.0-85026508632</pub-id><?supplied-pmid 28762847?><pub-id pub-id-type="pmid">28762847</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahromi</surname><given-names>Z.</given-names></name><name><surname>Mohammadghasemi</surname><given-names>F.</given-names></name><name><surname>Moharrami Kasmaie</surname><given-names>F.</given-names></name><name><surname>Zaminy</surname><given-names>A.</given-names></name></person-group><article-title>Cinnamaldehyde enhanced functional recovery after sciatic nerve crush injury in rats</article-title><source><italic toggle="yes">Cells, Tissues, Organs</italic></source><year>2020</year><volume>209</volume><issue>1</issue><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1159/000507016</pub-id><?supplied-pmid 32392570?><pub-id pub-id-type="pmid">32392570</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Trans-cinnamaldehyde shows anti-depression effect in the forced swimming test and possible involvement of the endocannabinoid system</article-title><source><italic toggle="yes">Biochemical and Biophysical Research Communications</italic></source><year>2019</year><volume>518</volume><issue>2</issue><fpage>351</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2019.08.061</pub-id><pub-id pub-id-type="other">2-s2.0-85070565413</pub-id><pub-id pub-id-type="pmid">31421826</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeTure</surname><given-names>M. A.</given-names></name><name><surname>Dickson</surname><given-names>D. W.</given-names></name></person-group><article-title>The neuropathological diagnosis of Alzheimer&#x02019;s disease</article-title><source><italic toggle="yes">Molecular Neurodegeneration</italic></source><year>2019</year><volume>14</volume><issue>1</issue><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1186/s13024-019-0333-5</pub-id><pub-id pub-id-type="other">2-s2.0-85070224476</pub-id><?supplied-pmid 31375134?><pub-id pub-id-type="pmid">30630532</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S. K.</given-names></name><name><surname>Srivastav</surname><given-names>S.</given-names></name><name><surname>Yadav</surname><given-names>A. K.</given-names></name><name><surname>Srikrishna</surname><given-names>S.</given-names></name><name><surname>Perry</surname><given-names>G.</given-names></name></person-group><article-title>Overview of Alzheimer&#x02019;s disease and some therapeutic approaches targeting A<italic>&#x003b2;</italic> by using several synthetic and herbal compounds</article-title><source><italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic></source><year>2016</year><volume>2016</volume><fpage>22</fpage><pub-id pub-id-type="doi">10.1155/2016/7361613</pub-id><pub-id pub-id-type="other">2-s2.0-84957081217</pub-id><?supplied-pmid 27034741?><pub-id pub-id-type="pmid">27034741</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momtaz</surname><given-names>S.</given-names></name><name><surname>Hassani</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>F.</given-names></name><name><surname>Ziaee</surname><given-names>M.</given-names></name><name><surname>Abdollahi</surname><given-names>M.</given-names></name></person-group><article-title>Cinnamon, a promising prospect towards Alzheimer&#x02019;s disease</article-title><source><italic toggle="yes">Pharmacological Research</italic></source><year>2018</year><volume>130</volume><fpage>241</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2017.12.011</pub-id><pub-id pub-id-type="other">2-s2.0-85039152025</pub-id><?supplied-pmid 29258915?><pub-id pub-id-type="pmid">29258915</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>H. M.</given-names></name><name><surname>Xu</surname><given-names>A.</given-names></name><name><surname>Schriner</surname><given-names>S. E.</given-names></name><name><surname>Sevrioukov</surname><given-names>E. A.</given-names></name><name><surname>Jafari</surname><given-names>M.</given-names></name></person-group><article-title>Cinnamaldehyde improves lifespan and healthspan in Drosophila melanogaster models for Alzheimer&#x02019;s disease</article-title><source><italic toggle="yes">BioMed Research International</italic></source><year>2018</year><volume>2018</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1155/2018/3570830</pub-id><pub-id pub-id-type="other">2-s2.0-85053428568</pub-id><pub-id pub-id-type="publisher-id">3570830</pub-id><?supplied-pmid 30228985?><pub-id pub-id-type="pmid">30228985</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustafa</surname><given-names>H. N.</given-names></name></person-group><article-title>Neuro-amelioration of cinnamaldehyde in aluminum-induced Alzheimer&#x02019;s disease rat model</article-title><source><italic toggle="yes">Journal of Histotechnology</italic></source><year>2020</year><volume>43</volume><issue>1</issue><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1080/01478885.2019.1652994</pub-id><pub-id pub-id-type="other">2-s2.0-85071327334</pub-id><?supplied-pmid 31460853?><pub-id pub-id-type="pmid">31460853</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name></person-group><article-title>Multi-target design strategies for the improved treatment of Alzheimer&#x02019;s disease</article-title><source><italic toggle="yes">European Journal of Medicinal Chemistry</italic></source><year>2019</year><volume>176</volume><fpage>228</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.05.020</pub-id><pub-id pub-id-type="other">2-s2.0-85065663130</pub-id><?supplied-pmid 31103902?><pub-id pub-id-type="pmid">31103902</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname><given-names>P. V.</given-names></name><name><surname>Steadman</surname><given-names>D.</given-names></name><name><surname>Bayle</surname><given-names>E. D.</given-names></name><name><surname>Whiting</surname><given-names>P.</given-names></name></person-group><article-title>New approaches for the treatment of Alzheimer&#x02019;s disease</article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry Letters</italic></source><year>2019</year><volume>29</volume><issue>2</issue><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2018.11.034</pub-id><pub-id pub-id-type="other">2-s2.0-85057218790</pub-id><?supplied-pmid 30501965?><pub-id pub-id-type="pmid">30501965</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease</article-title><source><italic toggle="yes">European Journal of Medicinal Chemistry</italic></source><year>2019</year><volume>168</volume><fpage>207</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.02.053</pub-id><pub-id pub-id-type="other">2-s2.0-85062002063</pub-id><?supplied-pmid 30822710?><pub-id pub-id-type="pmid">30822710</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>R. C.</given-names></name><name><surname>Lew</surname><given-names>J.</given-names></name><name><surname>Graves</surname><given-names>D. J.</given-names></name></person-group><article-title>Interaction of cinnamaldehyde and epicatechin with tau: implications of beneficial effects in modulating Alzheimer's disease pathogenesis</article-title><source><italic toggle="yes">Journal of Alzheimer's Disease</italic></source><year>2013</year><volume>36</volume><issue>1</issue><fpage>21</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.3233/JAD-122113</pub-id><pub-id pub-id-type="other">2-s2.0-84878869524</pub-id><?supplied-pmid 23531502?><pub-id pub-id-type="pmid">23531502</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramshini</surname><given-names>H.</given-names></name><name><surname>Ebrahim-Habibi</surname><given-names>A.</given-names></name><name><surname>Aryanejad</surname><given-names>S.</given-names></name><name><surname>Rad</surname><given-names>A.</given-names></name></person-group><article-title>Effect of cinnamomum verum extract on the amyloid formation of hen egg-white lysozyme and study of its possible role in Alzheimer&#x02019;s disease</article-title><source><italic toggle="yes">Basic and clinical neuroscience</italic></source><year>2015</year><volume>6</volume><issue>1</issue><fpage>29</fpage><lpage>37</lpage><?supplied-pmid 27504154?><pub-id pub-id-type="pmid">27504154</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>M.</given-names></name><name><surname>Ghadiri</surname><given-names>A.</given-names></name><name><surname>Hadizadeh</surname><given-names>F.</given-names></name><name><surname>Attaranzadeh</surname><given-names>A.</given-names></name><name><surname>Alavi</surname><given-names>M. S.</given-names></name><name><surname>Etemad</surname><given-names>L.</given-names></name></person-group><article-title>Cinnamaldehyde improves methamphetamine-induced spatial learning and memory deficits and restores ERK signaling in the rat prefrontal cortex</article-title><source><italic toggle="yes">Iranian Journal of Basic Medical Sciences</italic></source><year>2018</year><volume>21</volume><issue>12</issue><fpage>1316</fpage><lpage>1321</lpage><pub-id pub-id-type="doi">10.22038/IJBMS.2018.35368.8427</pub-id><?supplied-pmid 30627377?><pub-id pub-id-type="pmid">30627377</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Trans-cinnamaldehyde improves neuroinflammation-mediated NMDA receptor dysfunction and memory deficits through blocking NF-<italic>&#x003ba;</italic>B pathway in presenilin1/2 conditional double knockout mice</article-title><source><italic toggle="yes">Brain, Behavior, and Immunity</italic></source><year>2019</year><volume>82</volume><fpage>45</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2019.07.032</pub-id><pub-id pub-id-type="other">2-s2.0-85070271221</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Herbal compounds play a role in neuroprotection through the inhibition of microglial activation</article-title><source><italic toggle="yes">Journal of Immunology Research</italic></source><year>2018</year><volume>2018</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1155/2018/9348046</pub-id><pub-id pub-id-type="other">2-s2.0-85054766157</pub-id><pub-id pub-id-type="publisher-id">9348046</pub-id><?supplied-pmid 29850641?><pub-id pub-id-type="pmid">29850641</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SoukhakLari</surname><given-names>R.</given-names></name><name><surname>Borhani-Haghighi</surname><given-names>A.</given-names></name><name><surname>Farsadrooh</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The effect of cinnamaldehyde on passive avoidance memory and hippocampal Akt, ERK and GSK-3<italic>&#x003b2;</italic> in mice</article-title><source><italic toggle="yes">European Journal of Pharmacology</italic></source><year>2019</year><volume>859</volume><fpage>p. 172530</fpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2019.172530</pub-id><pub-id pub-id-type="other">2-s2.0-85068435176</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abou el-ezz</surname><given-names>D.</given-names></name><name><surname>Maher</surname><given-names>A.</given-names></name><name><surname>Sallam</surname><given-names>N.</given-names></name><name><surname>el-brairy</surname><given-names>A.</given-names></name><name><surname>Kenawy</surname><given-names>S.</given-names></name></person-group><article-title>Trans-cinnamaldehyde modulates hippocampal Nrf2 factor and inhibits amyloid beta aggregation in LPS-induced neuroinflammation mouse model</article-title><source><italic toggle="yes">Neurochemical Research</italic></source><year>2018</year><volume>43</volume><issue>12</issue><fpage>2333</fpage><lpage>2342</lpage><pub-id pub-id-type="doi">10.1007/s11064-018-2656-y</pub-id><pub-id pub-id-type="other">2-s2.0-85055050872</pub-id><?supplied-pmid 30302613?><pub-id pub-id-type="pmid">30302613</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Trans-cinnamaldehyde improves memory impairment by blocking microglial activation through the destabilization of iNOS mRNA in mice challenged with lipopolysaccharide</article-title><source><italic toggle="yes">Neuropharmacology</italic></source><year>2016</year><volume>110</volume><issue>Part A</issue><fpage>503</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.08.013</pub-id><pub-id pub-id-type="other">2-s2.0-84983650267</pub-id><?supplied-pmid 27543415?><pub-id pub-id-type="pmid">27543415</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>K.-J.</given-names></name><name><surname>Lin</surname><given-names>K. L.</given-names></name><name><surname>Chen</surname><given-names>S. D.</given-names></name><etal/></person-group><article-title>The overcrowded crossroads: mitochondria, alpha-synuclein, and the endo-lysosomal system interaction in Parkinson&#x02019;s disease</article-title><source><italic toggle="yes">International Journal of Molecular Sciences</italic></source><year>2019</year><volume>20</volume><issue>21</issue><fpage>p. 5312</fpage><pub-id pub-id-type="doi">10.3390/ijms20215312</pub-id><?supplied-pmid 31731450?><pub-id pub-id-type="pmid">31731450</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Casacuberta</surname><given-names>I.</given-names></name><name><surname>Ju&#x000e1;rez-Flores</surname><given-names>D. L.</given-names></name><name><surname>Mor&#x000e9;n</surname><given-names>C.</given-names></name><name><surname>Garrabou</surname><given-names>G.</given-names></name></person-group><article-title>Bioenergetics and autophagic imbalance in patients-derived cell models of Parkinson disease supports systemic dysfunction in neurodegeneration</article-title><source><italic toggle="yes">Frontiers in Neuroscience</italic></source><year>2019</year><volume>13</volume><fpage>p. 894</fpage><pub-id pub-id-type="doi">10.3389/fnins.2019.00894</pub-id><pub-id pub-id-type="other">2-s2.0-85073011882</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamebozorgi</surname><given-names>K.</given-names></name><name><surname>Taghizadeh</surname><given-names>E.</given-names></name><name><surname>Rostami</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Cellular and molecular aspects of Parkinson treatment: future therapeutic perspectives</article-title><source><italic toggle="yes">Molecular Neurobiology</italic></source><year>2019</year><volume>56</volume><issue>7</issue><fpage>4799</fpage><lpage>4811</lpage><pub-id pub-id-type="doi">10.1007/s12035-018-1419-8</pub-id><pub-id pub-id-type="other">2-s2.0-85056171769</pub-id><?supplied-pmid 30397850?><pub-id pub-id-type="pmid">30397850</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zesiewicz</surname><given-names>T. A.</given-names></name></person-group><article-title>Parkinson disease</article-title><source><italic toggle="yes">CONTINUUM: Lifelong Learning in Neurology</italic></source><year>2019</year><volume>25</volume><issue>4</issue><fpage>896</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1212/CON.0000000000000764</pub-id><pub-id pub-id-type="other">2-s2.0-85070577133</pub-id><?supplied-pmid 31356286?><pub-id pub-id-type="pmid">31356286</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tung</surname><given-names>Y.-T.</given-names></name><name><surname>Chua</surname><given-names>M. T.</given-names></name><name><surname>Wang</surname><given-names>S. Y.</given-names></name><name><surname>Chang</surname><given-names>S. T.</given-names></name></person-group><article-title>Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs</article-title><source><italic toggle="yes">Bioresource Technology</italic></source><year>2008</year><volume>99</volume><issue>9</issue><fpage>3908</fpage><lpage>3913</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2007.07.050</pub-id><pub-id pub-id-type="other">2-s2.0-43849093857</pub-id><pub-id pub-id-type="pmid">17826984</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannappan</surname><given-names>R.</given-names></name><name><surname>Gupta</surname><given-names>S. C.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Reuter</surname><given-names>S.</given-names></name><name><surname>Aggarwal</surname><given-names>B. B.</given-names></name></person-group><article-title>Neuroprotection by spice-derived nutraceuticals: you are what you eat!</article-title><source><italic toggle="yes">Molecular Neurobiology</italic></source><year>2011</year><volume>44</volume><issue>2</issue><fpage>142</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1007/s12035-011-8168-2</pub-id><pub-id pub-id-type="other">2-s2.0-80054858444</pub-id><?supplied-pmid 21360003?><pub-id pub-id-type="pmid">21360003</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khasnavis</surname><given-names>S.</given-names></name><name><surname>Pahan</surname><given-names>K.</given-names></name></person-group><article-title>Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson&#x02019;s disease</article-title><source><italic toggle="yes">Journal of Neuroimmune Pharmacology</italic></source><year>2014</year><volume>9</volume><issue>4</issue><fpage>569</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1007/s11481-014-9552-2</pub-id><pub-id pub-id-type="other">2-s2.0-84906337071</pub-id><?supplied-pmid 24946862?><pub-id pub-id-type="pmid">24946862</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jana</surname><given-names>A.</given-names></name><name><surname>Modi</surname><given-names>K. K.</given-names></name><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Anderson</surname><given-names>J. A.</given-names></name><name><surname>van Breemen</surname><given-names>R. B.</given-names></name><name><surname>Pahan</surname><given-names>K.</given-names></name></person-group><article-title>Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders</article-title><source><italic toggle="yes">Journal of Neuroimmune Pharmacology</italic></source><year>2013</year><volume>8</volume><issue>3</issue><fpage>739</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1007/s11481-013-9447-7</pub-id><pub-id pub-id-type="other">2-s2.0-84878793711</pub-id><?supplied-pmid 23475543?><pub-id pub-id-type="pmid">23475543</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khasnavis</surname><given-names>S.</given-names></name><name><surname>Pahan</surname><given-names>K.</given-names></name></person-group><article-title>Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons</article-title><source><italic toggle="yes">Journal of Neuroimmune Pharmacology</italic></source><year>2012</year><volume>7</volume><issue>2</issue><fpage>424</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1007/s11481-011-9286-3</pub-id><pub-id pub-id-type="other">2-s2.0-84862486817</pub-id><?supplied-pmid 21701815?><pub-id pub-id-type="pmid">21701815</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>C.-H.</given-names></name><name><surname>Mok</surname><given-names>S. Z. S.</given-names></name><name><surname>Koh</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila</article-title><source><italic toggle="yes">Journal of Neuroscience</italic></source><year>2009</year><volume>29</volume><issue>36</issue><fpage>11257</fpage><lpage>11262</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2375-09.2009</pub-id><pub-id pub-id-type="other">2-s2.0-70349103837</pub-id><?supplied-pmid 19741132?><pub-id pub-id-type="pmid">19741132</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pahan</surname><given-names>P.</given-names></name><name><surname>Pahan</surname><given-names>K.</given-names></name></person-group><article-title>Can cinnamon bring aroma in Parkinson's disease treatment?</article-title><source><italic toggle="yes">Neural Regeneration Research</italic></source><year>2015</year><volume>10</volume><issue>1</issue><fpage>30</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.4103/1673-5374.150647</pub-id><pub-id pub-id-type="other">2-s2.0-84923025707</pub-id><?supplied-pmid 25788911?><pub-id pub-id-type="pmid">25788911</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramazani</surname><given-names>E.</given-names></name><name><surname>YazdFazeli</surname><given-names>M.</given-names></name><name><surname>Emami</surname><given-names>S. A.</given-names></name><etal/></person-group><article-title>Protective effects of Cinnamomum verum, Cinnamomum cassia and cinnamaldehyde against 6-OHDA-induced apoptosis in PC12 cells</article-title><source><italic toggle="yes">Molecular Biology Reports</italic></source><year>2020</year><volume>47</volume><issue>4</issue><fpage>2437</fpage><lpage>2445</lpage><pub-id pub-id-type="doi">10.1007/s11033-020-05284-y</pub-id><pub-id pub-id-type="pmid">32166553</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>W.-Y.</given-names></name><name><surname>Choi</surname><given-names>J.-S.</given-names></name><name><surname>Jeong</surname><given-names>J.-W.</given-names></name></person-group><article-title>The neuroprotective effects of cinnamic aldehyde in an MPTP mouse model of Parkinson&#x02019;s disease</article-title><source><italic toggle="yes">International Journal of Molecular Sciences</italic></source><year>2018</year><volume>19</volume><issue>2</issue><fpage>p. 551</fpage><pub-id pub-id-type="doi">10.3390/ijms19020551</pub-id><pub-id pub-id-type="other">2-s2.0-85042163306</pub-id><?supplied-pmid 29439518?><pub-id pub-id-type="pmid">29439518</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Chemical structures of natural cinnamaldehyde derivatives.</p></caption><graphic xlink:href="BMRI2020-1034325.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Schematic diagram of cinnamaldehyde extraction and its ability to reduce neuronal cell death through the inhibition of mitochondrial dysfunction, nitrite oxide (NO) production, and inflammatory pathways.</p></caption><graphic xlink:href="BMRI2020-1034325.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Neuroprotective effects of cinnamaldehyde on neuroinflammation, oxidative stress, and mitochondrial dysfunction. Abbreviation: PAMP: pathogen-associated molecular pattern; DAMP: damage-associated molecular pattern.</p></caption><graphic xlink:href="BMRI2020-1034325.003"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Experimental studies of natural cinnamaldehyde and its derivation on neurological diseases.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Natural cinnamaldehyde derivation</th><th align="center" rowspan="1" colspan="1">Model</th><th align="center" rowspan="1" colspan="1">Animal/cell</th><th align="center" rowspan="1" colspan="1">Effective dose</th><th align="center" rowspan="1" colspan="1">Mechanism</th><th align="center" rowspan="1" colspan="1">Result</th><th align="center" rowspan="1" colspan="1">Main effect</th><th align="left" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">Permanent cerebral ischemia</td><td align="center" rowspan="1" colspan="1">Mouse</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">Suppress the activation of TLR4, TRAF6, and NF-<italic>&#x003ba;</italic>B signaling</td><td align="center" rowspan="1" colspan="1">Attenuate levels of TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, CCL2, and ELAM-1</td><td align="center" rowspan="1" colspan="1">Anti-inflammatory effect</td><td align="left" rowspan="1" colspan="1">[<xref rid="B31" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">Glutamate toxicity</td><td align="center" rowspan="1" colspan="1">PC12 cells</td><td align="center" rowspan="1" colspan="1">20&#x02009;<italic>&#x003bc;</italic>M</td><td align="center" rowspan="1" colspan="1">Inhibit intracellular ROS accumulation, increase Bcl-2 expression, inhibit Bax expression, block the release of cytochrome c, and decrease the LC3-II/LC3-I ratio</td><td align="center" rowspan="1" colspan="1">Maintain normal mitochondrial membrane potential and prevent the activation of autophagy</td><td align="center" rowspan="1" colspan="1">Antioxidative stress and antiapoptotic effects</td><td align="left" rowspan="1" colspan="1">[<xref rid="B17" ref-type="bibr">17</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">Diabetic neuropathy</td><td align="center" rowspan="1" colspan="1">DRG</td><td align="center" rowspan="1" colspan="1">100&#x02009;nmol/L</td><td align="center" rowspan="1" colspan="1">Inhibits the activation of NF-<italic>&#x003ba;</italic>B pathway</td><td align="center" rowspan="1" colspan="1">Attenuate caspase-3 activation and downregulate IL-6, TNF-<italic>&#x003b1;</italic>, COX, and iNOS levels</td><td align="center" rowspan="1" colspan="1">Anti-inflammatory effect</td><td align="left" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">Sciatic nerve crush</td><td align="center" rowspan="1" colspan="1">Rat</td><td align="center" rowspan="1" colspan="1">30&#x02009;mg/kg/day</td><td align="center" rowspan="1" colspan="1">Upregulate the number of regenerated nerves and Schwann cells</td><td align="center" rowspan="1" colspan="1">Promote nerve regeneration, motor function recovery, and muscle mass</td><td align="center" rowspan="1" colspan="1">Neuroprotective effect</td><td align="left" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">TCA</td><td align="center" rowspan="1" colspan="1">Depression</td><td align="center" rowspan="1" colspan="1">Mouse</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">Regulate the level of GABA neurotransmitter and also regulate the eCB system by downregulation of TRPV1 and CB1</td><td align="center" rowspan="1" colspan="1">Antidepressive effect</td><td align="left" rowspan="1" colspan="1">[<xref rid="B39" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">HCA</td><td align="center" rowspan="1" colspan="1">LPS-induced neuroinflammation</td><td align="center" rowspan="1" colspan="1">BV-2 microglial cells</td><td align="center" rowspan="1" colspan="1">2&#x02009;<italic>&#x003bc;</italic>M</td><td align="center" rowspan="1" colspan="1">Inhibit ERK, JNK, p38 MAPK, and NF-<italic>&#x003ba;</italic>B activation by target LRP1 and reduce microglia-mediated neuroblastoma cell death</td><td align="center" rowspan="1" colspan="1">Attenuate the expression of iNOS and proinflammatory cytokines such as IL-1<italic>&#x003b2;</italic> and TNF-<italic>&#x003b1;</italic></td><td align="center" rowspan="1" colspan="1">Anti-inflammatory and neuroprotective effects</td><td align="left" rowspan="1" colspan="1">[<xref rid="B19" ref-type="bibr">19</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: HCA: 2-hydroxycinnamaldehyde; MCA: 2-methoxycinnamaldehyde; DRG: dorsal root ganglion neurons; LPS: lipopolysaccharide; TRAF6: tumor necrosis receptor-associated factor 6; TLR4: Toll-like receptor 4; eCB: endocannabinoid; MAPKs: mitogen-activated protein kinases, ERK: extracellular-regulated kinase; JNK: c-Jun N-terminal kinase; COX: cyclooxygenase; iNOS: inducible nitric oxide synthase; NO: nitric oxide; IL-1<italic>&#x003b2;</italic>: interleukin-1<italic>&#x003b2;</italic>; IL-6: interleukin-6; TNF-<italic>&#x003b1;</italic>: tumor necrosis factor-<italic>&#x003b1;</italic>; NF-<italic>&#x003ba;</italic>B: nuclear factor kappa B; TRPA1: transient receptor potential ankyrin 1; ROS: reactive oxygen species; MDA: malondialdehyde; Bcl-2: B cell lymphoma 2; BAX: BCL2-Associated X; CCL2: C-C Motif Chemokine Ligand 2; ELAM-1: endothelial-leukocyte adhesion molecule 1; GABA: Gamma-Aminobutyric acid; TRPV1: transient receptor potential cation channel subfamily V member 1; LRP1: low-density lipoprotein receptor-related protein 1; LC3: microtubule-associated protein light chain 3.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" content-type="sidewaystable" orientation="portrait" position="float"><label>Table 2</label><caption><p>Preclinical studies of natural cinnamaldehyde and its derivation-mediated neuroprotective effects on Alzheimer's disease and Parkinson's disease models.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="center" rowspan="1" colspan="1">Animal/cell type</th><th align="center" rowspan="1" colspan="1">Injection route</th><th align="center" rowspan="1" colspan="1">Duration</th><th align="center" rowspan="1" colspan="1">Compound</th><th align="center" rowspan="1" colspan="1">Effective dose</th><th align="center" rowspan="1" colspan="1">Mechanism</th><th align="center" rowspan="1" colspan="1">Main finding</th><th align="center" rowspan="1" colspan="1">Behavioral assessment</th><th align="center" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Drosophila melanogaster (overexpressing A<italic>&#x003b2;</italic> or Tau proteins)</td><td align="center" rowspan="1" colspan="1">Fly</td><td align="center" rowspan="1" colspan="1">CA added to yeast paste</td><td align="center" rowspan="1" colspan="1">100 days</td><td align="center" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">80&#x02009;mM</td><td align="center" rowspan="1" colspan="1">Activate the autophagy pathway by Nrf2</td><td align="center" rowspan="1" colspan="1">Improve the lifespan and healthspan of male AD flies</td><td align="center" rowspan="1" colspan="1">Improve climbing ability and improve short-term memory</td><td align="center" rowspan="1" colspan="1">[<xref rid="B43" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Tau 187</td><td align="center" rowspan="1" colspan="1">_</td><td align="center" rowspan="1" colspan="1">Incubation</td><td align="center" rowspan="1" colspan="1">17&#x02009;h</td><td align="center" rowspan="1" colspan="1">CA and epicatechin</td><td align="center" rowspan="1" colspan="1">110&#x02009;<italic>&#x003bc;</italic>M</td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">Reduce tau aggregation</td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">[<xref rid="B48" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Aluminum chloride (alcl3-) induced Alzheimer's disease</td><td align="center" rowspan="1" colspan="1">Rat</td><td align="center" rowspan="1" colspan="1">Oral gavage</td><td align="center" rowspan="1" colspan="1">60 days</td><td align="center" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">Reduce the GFAP-positive cells</td><td align="center" rowspan="1" colspan="1">Reduce the progression of neurofibrillary degeneration, loss of dendritic spines, and appearance of neuritic plaques</td><td align="center" rowspan="1" colspan="1">Improve T-maze test</td><td align="center" rowspan="1" colspan="1">[<xref rid="B44" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Presenilin 1/2 conditional double knockout mice</td><td align="center" rowspan="1" colspan="1">Mouse</td><td align="center" rowspan="1" colspan="1">IP</td><td align="center" rowspan="1" colspan="1">90 days</td><td align="center" rowspan="1" colspan="1">TCA</td><td align="center" rowspan="1" colspan="1">240&#x02009;ppm</td><td align="center" rowspan="1" colspan="1">Suppress the NF-<italic>&#x003ba;</italic>b signaling pathway</td><td align="center" rowspan="1" colspan="1">Prevent the upregulation of iNOS, COX-2, IL-1<italic>&#x003b2;</italic>, and TNF-<italic>&#x003b1;</italic> and rescue memory impairment and synaptic dysfunction</td><td align="center" rowspan="1" colspan="1">Improve novel object recognition test, Morris water maze, and Y-maze</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Methamphetamine-induced spatial learning and memory deficits</td><td align="center" rowspan="1" colspan="1">Rat</td><td align="center" rowspan="1" colspan="1">IP</td><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">80&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">Activate the ERK signaling pathway</td><td align="center" rowspan="1" colspan="1">Improve cognitive and learning functions</td><td align="center" rowspan="1" colspan="1">Improve memory impairment in Morris water maze</td><td align="center" rowspan="1" colspan="1">[<xref rid="B50" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">LPS</td><td align="center" rowspan="1" colspan="1">Mouse/primary microglia</td><td align="center" rowspan="1" colspan="1">IP/incubation</td><td align="center" rowspan="1" colspan="1">28 days</td><td align="center" rowspan="1" colspan="1">TCA</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg/kg/10&#x02009;<italic>&#x003bc;</italic>M</td><td align="center" rowspan="1" colspan="1">Inhibit MEK1/2-ERK1/2 signaling pathway</td><td align="center" rowspan="1" colspan="1">Decrease NO production and IL-1<italic>&#x003b2;</italic> release in primary microglia and improve memory impairment</td><td align="center" rowspan="1" colspan="1">Improve open field, novel object recognition task, and Morris water maze test</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">LPS</td><td align="center" rowspan="1" colspan="1">Mouse</td><td align="center" rowspan="1" colspan="1">IP</td><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">TCA</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg/kg/day</td><td align="center" rowspan="1" colspan="1">Inhibit the NF-<italic>&#x003ba;</italic>B activation and attenuate the level of IL1<italic>&#x003b2;</italic>, MDA, and caspase-3</td><td align="center" rowspan="1" colspan="1">Modulate Nrf2 antioxidant defense in the hippocampus, inhibit neuroinflammation, apoptosis, and amyloid protein burden</td><td align="center" rowspan="1" colspan="1">Improve spatial and nonspatial memories impairment in Morris water maze and object recognition test</td><td align="center" rowspan="1" colspan="1">[<xref rid="B52" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">MPTP/MPP<sup>+</sup>-induced neuronal cell injury</td><td align="center" rowspan="1" colspan="1">Mouse/human neuroblastoma BE(2)-M17 cells</td><td align="center" rowspan="1" colspan="1">IP</td><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">10&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">Upregulate p62 and reduce the rate of autophagy</td><td align="center" rowspan="1" colspan="1">Inhibit autophagy</td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">[<xref rid="B66" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">6-OHDA</td><td align="center" rowspan="1" colspan="1">PC12 cell lines</td><td align="center" rowspan="1" colspan="1">Incubation</td><td align="center" rowspan="1" colspan="1">24&#x02009;h</td><td align="center" rowspan="1" colspan="1">CA</td><td align="center" rowspan="1" colspan="1">10&#x02009;<italic>&#x003bc;</italic>M</td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">Increase viability of 6-OHDA-treated cells and decrease the ROS generation</td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">[<xref rid="B65" ref-type="bibr">65</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>AD: Alzheimer's disease; PD: Parkinson disease; CA: cinnamaldehyde; MPTP: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, MPP+: 1-methyl-4 phenylpyridinium; Nrf2: nuclear factor erythroid 2-related factor 2; ROS: reactive oxygen species; 6-OHDA: 6-hydroxydopamine; IP: intraperitoneal; COX2: cyclo-oxygenase 2; IL-1<italic>&#x003b2;</italic>: interleukin-1<italic>&#x003b2;</italic>; TNF-<italic>&#x003b1;</italic>: tumor necrosis factor-<italic>&#x003b1;</italic>.</p></fn></table-wrap-foot></table-wrap></floats-group></article>